eXroid Technology Ltd is one of the first companies to be awarded a King’s Award for Enterprise: Innovation. This accolade represents a milestone for the company as we reach for new heights and strive for better: for our patients, for our partners and for future sufferers.
This prestigious accolade has been awarded to eXroid for their work in developing a highly safe and effective, fully ambulatory treatment for haemorrhoid sufferers, meaning that they are no longer faced with a choice of treatment options that are known to be extremely painful and carry risks of complications, to become symptom free. The eXroid® procedure has advanced the science and understanding of the disease which affects around 9% of the UK population each year to improve the patient pathway for all sufferers.
After discovering and being successfully treated with this innovative procedure, Graham made it his objective to make it available for all sufferers. His pride in eXroid® receiving this award is only exceeded by the gratitude he has for the team who have worked tirelessly to make this business a success.
eXroid is a ‘life changing’ option for anyone suffering from this common and debilitating condition. It changed my life and it’s been my mission to make it available for everyone else out there who is suffering. The team and capability we have built has been way beyond my expectations. We have an unbelievable culture and we are all committed to improve the clinical science and availability of safe effective care for this condition, across the globe.
Graham Bason – Founder and Commercial Executive Director
The newly renamed King’s Award for Enterprise celebrates outstanding achievement by UK businesses and is internationally recognised.
It was established during Queen Elizabeth II’s reign and conferred in Her Late Majesty’s name, has been renamed to reflect King Charles III’s Accession. Throughout Her Late Majesty’s 70-year reign, Queen Elizabeth II was committed to recognising outstanding work and acts of service by individuals and groups. By attaching His Majesty’s name to these awards, The King has emphasised his desire to continue Queen Elizabeth’s legacy of recognising outstanding businesses.
Since the Award’s inception in 1965 more than 7,000 companies have been awarded. In contrast, nearly 60,000 entries have been received, meaning less than 12% of entries will end up winning an award. The largest category in the awards is the INTERNATIONAL TRADE category, which makes up over half the entires each year. This year just xx (yy%) of awards were given in the category of INNOVATION – with eXroid being one of these.
Since 2020, there have only been 26 winners in the South East of England in the INNOVATION category. We are in good company – with previous winners going on to achieve continued success.
Being part of the eXroid family and seeing us through this momentous milestone has been a personal and professional highlight.
Those who have been through the application process will understand the painstaking effort it takes to complete. This effort is demonstrated across the team in all aspects of our business and as we strive for a better patient pathway for all haemorrhoid sufferers. We are so proud to have been recognised for all the work we have done so far and are even more motivated for the future of eXroid.
Bonney Hallett – Director of Marketing and D2C Services
The eXroid® treatment takes 30 minutes or less. Effects can be felt from immediately and no waiting for a referral
The procedure is supported and carried out by the UK's leading specialist consultant surgeons in CQC registered clinics
The eXroid® procedure is low risk, as it requires no anaesthetic, cutting or stitching
Get back to your life straightaway, with no time off work needed after the eXroid® procedure
eXroid® electrotherapy is subject to NICE guidance (IPG525 & MIB201), is rated as Outstanding by the CQC and carries the CE mark